Tudor Investment Corp ET AL Has $1.31 Million Stake in Exponent, Inc. $EXPO

Tudor Investment Corp ET AL cut its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 67.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,916 shares of the business services provider’s stock after selling 39,556 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Exponent were worth $1,314,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. CIBC Bancorp USA Inc. acquired a new stake in shares of Exponent in the third quarter valued at about $377,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Exponent by 621.7% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,299 shares of the business services provider’s stock worth $90,000 after acquiring an additional 1,119 shares during the period. Voleon Capital Management LP boosted its holdings in Exponent by 428.9% in the third quarter. Voleon Capital Management LP now owns 59,689 shares of the business services provider’s stock valued at $4,147,000 after acquiring an additional 48,404 shares during the last quarter. Voloridge Investment Management LLC boosted its holdings in Exponent by 44.2% in the third quarter. Voloridge Investment Management LLC now owns 255,147 shares of the business services provider’s stock valued at $17,728,000 after acquiring an additional 78,237 shares during the last quarter. Finally, Verition Fund Management LLC increased its position in Exponent by 325.4% during the 3rd quarter. Verition Fund Management LLC now owns 44,100 shares of the business services provider’s stock valued at $3,064,000 after purchasing an additional 33,734 shares during the period. Institutional investors own 92.37% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on EXPO shares. UBS Group restated a “neutral” rating and set a $85.00 price target on shares of Exponent in a report on Monday, February 9th. JPMorgan Chase & Co. decreased their price objective on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a research note on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $90.00.

Insider Activity at Exponent

In other news, CEO Catherine Corrigan sold 3,920 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the transaction, the chief executive officer directly owned 93,731 shares of the company’s stock, valued at $6,294,036.65. This represents a 4.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP John Pye sold 4,000 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $75.97, for a total value of $303,880.00. Following the completion of the transaction, the vice president owned 25,204 shares in the company, valued at approximately $1,914,747.88. This represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 9,583 shares of company stock valued at $687,709. Corporate insiders own 1.60% of the company’s stock.

Exponent Stock Performance

Shares of NASDAQ EXPO opened at $64.47 on Monday. The firm has a market capitalization of $3.18 billion, a P/E ratio of 31.00 and a beta of 0.77. The firm’s 50-day moving average price is $70.74 and its 200-day moving average price is $70.63. Exponent, Inc. has a 1-year low of $63.25 and a 1-year high of $83.92.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, February 5th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a return on equity of 25.51% and a net margin of 18.21%.The company had revenue of $147.43 million during the quarter, compared to the consensus estimate of $128.48 million. During the same period last year, the business posted $0.46 EPS. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. Equities research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Friday, March 6th were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. This is a boost from Exponent’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, March 6th. Exponent’s payout ratio is 59.62%.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.